| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Boehler Adam serves as a Director at PRVA. Across recent SEC filings that breaks down to 6 buys and 0 sells. Those positions are worth an estimated $128.6M at current prices.
Historically, Boehler Adam's trades have earned a strong insider score of 78/100 across 6 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +39.5%.
The biggest single holding is PRVA (~$128.6M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 562,386 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2024 | PRVA Privia Health Group, Inc. | Director | Buy | 364 | $16.50 | $6,006.00 | - | +11.5% | +37.5% | |
| May 29, 2024 | PRVA Privia Health Group, Inc. | Director | Buy | 5,306 | $16.50 | $87,549.00 | - | +26.6% | +37.5% | |
| May 24, 2024 | PRVA Privia Health Group, Inc. | Director | Buy | 4,280 | $16.49 | $70,577.20 | - | +15.5% | +32.1% | |
| May 23, 2024 | PRVA Privia Health Group, Inc. | Director | Buy | 552,436 | $16.25 | $8,978,460.28 | +3.4% | +20.6% | +41.9% |